|
| 36305841 | Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus-associated oropharyngeal cancer. | CA Cancer J Clin | 2023 |
| 37806780 | An essential goal within reach: attaining diversity, equity, and inclusion for the Journal of the National Cancer Institute journals. | J Natl Cancer Inst | 2023 |
| 37806772 | An essential goal within reach: attaining diversity, equity, and inclusion for the Journal of the National Cancer Institute journals. | JNCI Cancer Spectr | 2023 |
| 37561583 | Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma. | J Clin Invest | 2023 |
| 37620627 | Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial. | Nat Med | 2023 |
| 37587346 | Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers. | Nature | 2023 |
| 37945902 | Most large structural variants in cancer genomes can be detected without long reads. | Nat Genet | 2023 |
| 38045365 | Multi-Scale Geometric Network Analysis Identifies Melanoma Immunotherapy Response Gene Modules. | bioRxiv | 2023 |
| 37607324 | Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma. | J Clin Oncol | 2023 |
| 36944408 | Detection of Biallelic Loss of DNA Repair Genes in Formalin-Fixed, Paraffin-Embedded Tumor Samples Using a Novel Tumor-Only Sequencing Panel. | J Mol Diagn | 2023 |
| 37439286 | Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer. | Head Neck | 2023 |
| 37435097 | Stem cell-like T cell depletion in the recurrent head and neck cancer immune microenvironment. | Oncoimmunology | 2023 |
| 37099979 | Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity. | Oral Oncol | 2023 |
| 36689229 | Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma. | JAMA Netw Open | 2023 |
| 36804617 | Impact of immune infiltration signatures on prognosis in endometrial carcinoma is dependent on the underlying molecular subtype. | Gynecol Oncol | 2023 |
| 36681089 | Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial. | Lancet Oncol | 2023 |
| 36602799 | Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab. | JAMA Netw Open | 2023 |
| 36894710 | Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors. | Nat Genet | 2023 |
| 34725502 | Improved prediction of immune checkpoint blockade efficacy across multiple cancer types. | Nat Biotechnol | 2022 |
| 35647395 | Peer Review of Head and Neck Cancer Planning Target Volumes in Radiation Oncology. | Adv Radiat Oncol | 2022 |
| 35472075 | Colorectal Cancer Develops Inherent Radiosensitivity That Can Be Predicted Using Patient-Derived Organoids. | Cancer Res | 2022 |
| 35817971 | Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity. | Nat Genet | 2022 |
| 35690646 | Prognostic impact of extranodal extension (ENE) in surgically managed treatment-naive HPV-positive oropharyngeal squamous cell carcinoma with nodal metastasis. | Mod Pathol | 2022 |
| 35521657 | A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image-Guided Stereotactic Body Radiotherapy in the Treatment of Metastatic Anaplastic Thyroid Cancer. | Thyroid | 2022 |
| 36411321 | A macrophage-activated abscopal effect. | Nat Cancer | 2022 |
| 36367724 | Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy. | JAMA Netw Open | 2022 |
| 36252564 | Transcriptional and functional analyses of neoantigen-specific CD4 T cells during a profound response to anti-PD-L1 in metastatic Merkel cell carcinoma. | J Immunother Cancer | 2022 |
| 35157996 | Effects of Tumor Mutational Burden and Gene Alterations Associated with Radiation Response on Outcomes of Postoperative Radiation Therapy in Non-Small Cell Lung Cancer. | Int J Radiat Oncol Biol Phys | 2022 |
| 34949653 | Cancer-Causative Mutations Occurring in Early Embryogenesis. | Cancer Discov | 2022 |
| 35050342 | Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy. | JAMA Oncol | 2022 |
| 32726432 | Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy. | J Natl Cancer Inst | 2021 |
| 33795234 | Synthetic Lethality in Cancer Therapeutics: The Next Generation. | Cancer Discov | 2021 |
| 33674143 | Molecular characterization of high-grade serous ovarian cancers occurring in younger and older women. | Gynecol Oncol | 2021 |
| 33893322 | Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development. | NPJ Breast Cancer | 2021 |
| 33863915 | TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer. | NPJ Breast Cancer | 2021 |
| 33586179 | Any day, split halfway: Flexibility in scheduling high-dose cisplatin-A large retrospective review from a high-volume cancer center. | Int J Cancer | 2021 |
| 33834176 | Mutations in <i>BRCA1</i> and <i>BRCA2</i> differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy. | Nat Cancer | 2021 |
| 33526794 | Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors. | Nat Commun | 2021 |
| 33606323 | Outcomes and prognostic factors of major salivary gland tumors treated with proton beam radiation therapy. | Head Neck | 2021 |
| 34617275 | Current considerations for radiotherapy in HPV-associated head and neck cancer. | J Surg Oncol | 2021 |
| 34381934 | <i>TERT</i> Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence. | JCO Precis Oncol | 2021 |
| 34585792 | The effect of short radiation treatment breaks on chemo-radiotherapy for oropharyngeal cancers. | Head Neck | 2021 |
| 34635660 | Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination. | NPJ Breast Cancer | 2021 |
| 33990345 | Tumor Immunity and Immunotherapy for HPV-Related Cancers. | Cancer Discov | 2021 |
| 34293201 | Intensity-modulated radiation therapy and doxorubicin in thyroid cancer: A prospective phase 2 trial. | Cancer | 2021 |
| 33954225 | Reproducibility of radiomic features using network analysis and its application in Wasserstein <i>k</i>-means clustering. | J Med Imaging (Bellingham) | 2021 |
| 34143193 | Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy. | JAMA Netw Open | 2021 |
| 33197752 | The head and neck cancer genome in the era of immunotherapy. | Oral Oncol | 2021 |
| 33372007 | Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis. | Cancer Discov | 2021 |
| 33429428 | Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial. | J Natl Cancer Inst | 2021 |